Paul Wallace

Paul Wallace Email and Phone Number

Chief Business Officer at Constructive Bio; Chairman, NED @ Constructive Bio
Paul Wallace's Location
Greater Cambridge Area, United Kingdom, United Kingdom
Paul Wallace's Contact Details

Paul Wallace personal email

n/a
About Paul Wallace

CBO for a MRC Laboratory of Molecular Biology spin-out and Chairman/NED for a University of Cambridge, Cavendish Laboratory spin-out. Previously CBO/EVP, Head of Business Development for private and publicly-listed pharmaceutical companies. Member of executive teams that have raised >$200M and completed 5 trade sales/acquisitions. Executed out-licensing partnerships to a total value of $4.5B and that resulted in 2 drugs reaching the market, including the blockbuster Olysio®. Initial research career in UK biotechs. PhD and postdoc in biochemistry from the University of Cambridge.

Paul Wallace's Current Company Details
Constructive Bio

Constructive Bio

View
Chief Business Officer at Constructive Bio; Chairman, NED
Paul Wallace Work Experience Details
  • Constructive Bio
    Chief Business Officer
    Constructive Bio Oct 2023 - Present
    Whittlesford, Cambridge, Gb
    Constructive Bio is a spin-out from the MRC Laboratory of Molecular Biology. The Company's technologies allow for the synthesis and recoding of entire genomes, enabling the design and production of entirely novel and improved biomolecules with unprecedented functionalities. Investors include Ahren Innovation Capital, Amadeus Capital Partners, Fine Structure Ventures, General Inception, ND Capital, OMX Ventures and Paladin Capital Group. 2024 winner of the Cambridge Independent Science and Technology Award for Start-up of the Year.
  • Semarion
    Chairman, Non-Executive Director
    Semarion 2020 - Present
    Cambridge, Cambridgeshire, Gb
    University of Cambridge, Cavendish Laboratory spin-out that is using novel materials physics to develop micro-scale cell carriers for cell-based assays: turning adherent cells into liquid reagents; for miniaturization and cell multiplexing. 2024 winner of the SLAS Ignite Award for most innovative laboratory automation start-up in Europe. 2023 winner of the Business Weekly Pathfinder Award.
  • Life Science Companies
    Advisor / Mentor
    Life Science Companies 2013 - Present
  • Mission Therapeutics
    Chief Business Officer
    Mission Therapeutics Mar 2015 - Sep 2023
    Cambridge, Cambs, Gb
    Private pharmaceutical company. Targeting deubiquitylating enzymes to treat neurodegenerative disease, rare mitochondrial diseases, fibrosis, inflammation and cancers. Raised $125M venture capital from institutional and corporate investors. Strategic partnerships with AbbVie and Pfizer.
  • Medivir Ab
    Evp, Head Of Business Development
    Medivir Ab 2010 - Mar 2015
    Huddinge, Se
    Publicly listed pharmaceutical company. Head of business development during period when company took two drugs from research to launch (incl. HCV protease inhibitor Olysio®; $2B in first year with partner J&J) and transitioned from an early-stage R&D company into a profitable company with commercial sales. Executed 25 partnerships, the majority with major pharma.
  • Medivir Ab
    Vp, Head Of Business Development
    Medivir Ab 2000 - 2010
    Huddinge, Se
  • Acambis Plc; Peptide Therapeutics Plc
    Manager, Business Development
    Acambis Plc; Peptide Therapeutics Plc 1996 - 2000
    Public company, listed on LSE. Vaccines and protease inhibitor drugs. Trade sale to Sanofi-Aventis.
  • Eclagen Ltd
    Founding Director Of Research
    Eclagen Ltd 1995 - 1996
    Private company. Antibody engineering and therapeutics. Trade sale to Merck KGaA.
  • Scotgen Biopharmaceuticals Inc.
    Research Group Leader
    Scotgen Biopharmaceuticals Inc. 1991 - 1995
    Private company. Recombinant antibody therapeutics.Principal inventor of two humanised antibodies in late-stage clinical development for cancer indications: farletuzumab (phase III) and ontuxizumab (phase II).
  • University Of Cambridge
    Postdoctoral Research Assistant
    University Of Cambridge 1988 - 1991
    Cambridge, England, Gb
    Biochemistry and molecular biology. Cellular targeting and processing of proteins.

Paul Wallace Skills

Business Development Out Licensing Biotechnology Life Sciences Pharmaceutical Industry Corporate Development Strategic Partnerships Executive Team Licensing Venture Capital Drug Discovery Healthcare Research And Development Strategic Alliances Mentoring

Paul Wallace Education Details

  • University Of Cambridge
    University Of Cambridge
    Biochemistry And Molecular Biology
  • University Of St Andrews
    University Of St Andrews
    Biochemistry

Frequently Asked Questions about Paul Wallace

What company does Paul Wallace work for?

Paul Wallace works for Constructive Bio

What is Paul Wallace's role at the current company?

Paul Wallace's current role is Chief Business Officer at Constructive Bio; Chairman, NED.

What is Paul Wallace's email address?

Paul Wallace's email address is pa****@****ivir.se

What schools did Paul Wallace attend?

Paul Wallace attended University Of Cambridge, University Of St Andrews.

What skills is Paul Wallace known for?

Paul Wallace has skills like Business Development, Out Licensing, Biotechnology, Life Sciences, Pharmaceutical Industry, Corporate Development, Strategic Partnerships, Executive Team, Licensing, Venture Capital, Drug Discovery, Healthcare.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.